Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 10, 2013

UCB Inc. et al v. Glenmark Generics Inc. USA et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 11, 2013

    UCB Launches Legion Of Suits To Protect Epilepsy Drug IP

    German pharmaceuticals giant UCB Pharma GmbH hit more than a dozen generic-drug manufacturers with suits in Delaware federal court Wednesday, accusing Sandoz Inc., Amneal Pharmaceuticals LLC, Apotex Corp. and others of infringing one of its patents by seeking approval for generic forms of UCB's epilepsy drug Vimpat.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login